Security record · archived quarter
MDXG
MiMedx Group, Inc. · Healthcare · Biotechnology
16Tracked holders
0Δ holders
31.16MShares held
$190.41MReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +2.8% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 90 | 0 | 52.34M | $201.56M | +8 | −8 |
| Q1 2026 | 93 | 0 | 53.34M | $210.99M | +4 | −4 |
| Q4 2025 | 93 | +1 | 51.21M | $346.71M | +1 | n/a |
| Q3 2025 | 19 | 0 | 33.28M | $232.30M | n/a | n/a |
| Q2 2025 | 16 | 0 | 31.16M | $190.41M | +1 | −1 |
| Q1 2025 | 13 | -1 | 11.80M | $89.67M | n/a | −1 |
| Q4 2024 | 14 | +1 | 11.42M | $109.89M | +1 | n/a |
| Q3 2024 | 12 | -2 | 7.09M | $41.90M | n/a | −2 |
| Q2 2024 | 14 | n/a | 7.86M | $54.46M | n/a | n/a |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 11.53M | n/a | $70.42M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 2 | The Vanguard Group ✦ (passive) | 6.96M | n/a | $42.51M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passive) | 3.47M | +0.2% | $21.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 2.84M | -2.4% | $17.37M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 5 | Renaissance Technologies ✦ | 2.11M | +9.2% | $12.88M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 6 | Millennium Management ✦ | 1.67M | +35.9% | $10.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 791.78K | +30.5% | $4.84M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Citadel Advisors ✦ | 452.67K | +1.5% | $2.77M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | Marshall Wace ✦ | 379.16K | New | $2.32M | 0.0% | New | 1 | SEC ↗ ×2 |
| 10 | Wellington Management ✦ | 351.73K | -6.6% | $2.15M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 11 | Fisher Asset Management ✦ | 273.00K | 0.0% | $1.67M | 0.0% | Held | 5 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 102.88K | -68.3% | $628,609 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 98.96K | -2.3% | $604,664 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 79.30K | +54.9% | $486,000 | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 15 | AQR Capital Management ✦ | 33.94K | +136.1% | $207,355 | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
| 16 | Fidelity (FMR) ✦ | 25.90K | n/a | $158,264 | 0.0% | n/c | 1 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $2.32M | 0.0% |
Exited
| Norges Bank | $535,040 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 234 holders, 112.82M shares, $439.18M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API